Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Initial Review, 15306 [2016-06354]
Download as PDF
<![CDATA[
15306
Federal Register / Vol. 81, No. 55 / Tuesday, March 22, 2016 / Notices
Specifically, the Council makes
recommendations regarding policies,
strategies, objectives, and priorities;
addresses the development and
application of new technologies; and
reviews the extent to which progress has
been made toward eliminating
tuberculosis.
Matters for Discussion: Agenda items
include the following topics: (1)
Discussion on U.S. Preventive Services
Task Force (USPSTF)
Recommendations; (2) Draft of TB
Treatment Guidelines; (3) Updates from
Workgroups; and (4) other tuberculosisrelated issues.
Agenda items are subject to change as
priorities dictate.
Contact Person for More Information:
Margie Scott-Cseh, Centers for Disease
Control and Prevention, 1600 Clifton
Road, NE., M/S E–07, Atlanta, Georgia
30333, telephone (404) 639–8317;
Email: zkr7@cdc.gov.
The Director, Management Analysis
and Services Office, has been delegated
the authority to sign Federal Register
notices pertaining to announcements of
meetings and other committee
management activities, for both the
Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Claudette Grant,
Acting Director, Management Analysis and
Services Office, Centers for Disease Control
and Prevention.
Claudette Grant,
Acting Director, Management Analysis and
Services Office, Centers for Disease Control
and Prevention.
[FR Doc. 2016–06346 Filed 3–21–16; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
[FR Doc. 2016–06345 Filed 3–21–16; 8:45 am]
BILLING CODE 4163–18–P
Centers for Disease Control and
Prevention
asabaliauskas on DSK3SPTVN1PROD with NOTICES
Disease, Disability, and Injury
Prevention and Control Special
Emphasis Panel (SEP): Initial Review
In accordance with Section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC)
announces a meeting for the initial
review of applications in response to
Funding Opportunity Announcements
(FOA) CK16–002, Spatially Scalable
Integrated Tick Vector/Rodent Reservoir
Management to Reduce Human Risk of
Exposure to Ixodes Scapularis Ticks
Infected with Lyme Disease Spirochetes
and CK16–003, Pre-travel Health
Preparation of International Travelers:
Expanding and Improving Data
Collection, Guidance, and Outreach.
Time and Date: 10:00 a.m.–5:00 p.m.,
April 14, 2016 (Closed).
VerDate Sep<11>2014
17:34 Mar 21, 2016
Jkt 238001
Place: Teleconference.
Status: The meeting will be closed to
the public in accordance with
provisions set forth in Section
552b(c)(4) and (6), Title 5 U.S.C., and
the determination of the Director,
Management Analysis and Services
Office, CDC, pursuant to Public Law 92–
463.
Matters for Discussion: The meeting
will include the initial review,
discussion, and evaluation of
applications received in response to
‘‘Spatially Scalable Integrated Tick
Vector/Rodent Reservoir Management to
Reduce Human Risk of Exposure to
Ixodes Scapularis Ticks Infected with
Lyme Disease Spirochetes’’, CK16–002
and ‘‘Pre-travel Health Preparation of
International Travelers: Expanding and
Improving Data Collection, Guidance,
and Outreach’’, CK16–003.
Contact Person for More Information:
Gregory Anderson, M.S., M.P.H.,
Scientific Review Officer, CDC, 1600
Clifton Road NE., Mailstop E60, Atlanta,
Georgia 30333, Telephone: (404) 718–
8833.
The Director, Management Analysis
and Services Office, has been delegated
the authority to sign Federal Register
notices pertaining to announcements of
meetings and other committee
management activities, for both the
Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Disease, Disability, and Injury
Prevention and Control Special
Emphasis Panel (SEP): Initial Review
In accordance with Section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC)
announces a meeting for the initial
review of applications in response to
Special Interest Project (SIP) 16–001,
Evaluating the Adoption and
Implementation of an Evidence-based
Patient Navigation Intervention for
Colonoscopy Screening, SIP 16–002,
Formative Development of an
Instrument to Predict Adherence to
Active Surveillance (AS) for Localized
PO 00000
Frm 00087
Fmt 4703
Sfmt 4703
Prostate Cancer, and SIP 16–003,
Implementation of Community-based,
Small Media Interventions to Promote
Colorectal Cancer Screening Among
Chinese Americans.
Time and Date: 11:00 a.m.–6:00 p.m.,
EDT, April 21, 2016 (Closed).
Place: Teleconference.
Status: The meeting will be closed to
the public in accordance with
provisions set forth in Section
552b(c)(4) and (6), Title 5 U.S.C., and
the Determination of the Director,
Management Analysis and Services
Office, CDC, pursuant to Public Law 92–
463.
Matters for Discussion: The meeting
will include the initial review,
discussion, and evaluation of
applications received in response to
‘‘Evaluating the Adoption and
Implementation of an Evidence-based
Patient Navigation Intervention for
Colonoscopy Screening’’, SIP 16–001,
‘‘Formative Development of an
Instrument to Predict Adherence to
Active Surveillance (AS) for Localized
Prostate Cancer’’, SIP 16–002 and,
‘‘Implementation of Community-based,
Small Media Interventions to Promote
Colorectal Cancer’’, SIP 16–003.
Contact Person for More Information:
Jaya Raman Ph.D., Scientific Review
Officer, CDC, 4770 Buford Highway,
Mailstop F80, Atlanta, Georgia 30341,
Telephone: (770) 488–6511, kva5@
cdc.gov.
The Director, Management Analysis
and Services Office, has been delegated
the authority to sign Federal Register
notices pertaining to announcements of
meetings and other committee
management activities, for both the
Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Claudette Grant,
Acting Director, Management Analysis and
Services Office, Centers for Disease Control
and Prevention.
[FR Doc. 2016–06354 Filed 3–21–16; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Disease, Disability, and Injury
Prevention and Control Special
Emphasis Panel (SEP): Initial Review
In accordance with Section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC)
announces a meeting for the initial
E:\FR\FM\22MRN1.SGM
22MRN1
]]>Agencies
[Federal Register Volume 81, Number 55 (Tuesday, March 22, 2016)]
[Notices]
[Page 15306]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2016-06354]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Disease, Disability, and Injury Prevention and Control Special
Emphasis Panel (SEP): Initial Review
In accordance with Section 10(a)(2) of the Federal Advisory
Committee Act (Pub. L. 92-463), the Centers for Disease Control and
Prevention (CDC) announces a meeting for the initial review of
applications in response to Special Interest Project (SIP) 16-001,
Evaluating the Adoption and Implementation of an Evidence-based Patient
Navigation Intervention for Colonoscopy Screening, SIP 16-002,
Formative Development of an Instrument to Predict Adherence to Active
Surveillance (AS) for Localized Prostate Cancer, and SIP 16-003,
Implementation of Community-based, Small Media Interventions to Promote
Colorectal Cancer Screening Among Chinese Americans.
Time and Date: 11:00 a.m.-6:00 p.m., EDT, April 21, 2016 (Closed).
Place: Teleconference.
Status: The meeting will be closed to the public in accordance with
provisions set forth in Section 552b(c)(4) and (6), Title 5 U.S.C., and
the Determination of the Director, Management Analysis and Services
Office, CDC, pursuant to Public Law 92-463.
Matters for Discussion: The meeting will include the initial
review, discussion, and evaluation of applications received in response
to ``Evaluating the Adoption and Implementation of an Evidence-based
Patient Navigation Intervention for Colonoscopy Screening'', SIP 16-
001, ``Formative Development of an Instrument to Predict Adherence to
Active Surveillance (AS) for Localized Prostate Cancer'', SIP 16-002
and, ``Implementation of Community-based, Small Media Interventions to
Promote Colorectal Cancer'', SIP 16-003.
Contact Person for More Information: Jaya Raman Ph.D., Scientific
Review Officer, CDC, 4770 Buford Highway, Mailstop F80, Atlanta,
Georgia 30341, Telephone: (770) 488-6511, kva5@cdc.gov.
The Director, Management Analysis and Services Office, has been
delegated the authority to sign Federal Register notices pertaining to
announcements of meetings and other committee management activities,
for both the Centers for Disease Control and Prevention and the Agency
for Toxic Substances and Disease Registry.
Claudette Grant,
Acting Director, Management Analysis and Services Office, Centers for
Disease Control and Prevention.
[FR Doc. 2016-06354 Filed 3-21-16; 8:45 am]
BILLING CODE 4163-18-P
